Product ID: SQMIG35A2586
Left Atrial Appendage Closure Devices Market Size, Share, Growth Analysis, By Product(Endocardial LAA Devices, Epicardial LAA Devices), By Procedure(Percutaneous, Surgical), By End - Use(Hospitals, Ambulatory Surgical Centers) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2586 |
Region:
Global |
Published Date: March, 2024
Pages:
184
|
Tables:
88 |
Figures:
66
Left Atrial Appendage Closure Devices Market News
-
In January 2024, another strategy called the Laminar Device for shutting off a piece of the heart called the left atrial appendage (LAA) was created. This gadget is embedded through a little opening in the heart and has an enclosure toward the end that can be turned to seal the LAA shut, like tying a contort tie on a bread bag. An extraordinary security keeps the enclosure secure. Testing on creatures and people has shown promising outcomes, without any releases or complexities noted. This procedure might lessen the risk of specific complexities contrasted with different strategies.
-
On February 26, 2024, Catheter Precision, Inc., a US medical device company working in electrophysiology items, uncovered that it is introducing its LockeT suture closure device at the International Symposium on Left Atrial Appendage. The meeting is occurring at the Intercontinental New York Times Square from March 1 to 2, 2024.
-
In October 2023, FEops, known for personalized predictive preparation in structural heart interventions, declared a partnership with ConcertAI's TeraRecon. This collaboration plans to popularize FEops HEARTguide's work process for Left Atrial Appendage (LAA) impediment, especially focusing on the US market.
Left Atrial Appendage Closure Devices Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
